Ion Exchange Separation of the Antitumor Component(s) of Yogurt Dialyzate
Open Access
- 1 December 1982
- journal article
- Published by American Dairy Science Association in Journal of Dairy Science
- Vol. 65 (12) , 2388-2390
- https://doi.org/10.3168/jds.s0022-0302(82)82513-7
Abstract
The active antitumor component of yogurt obtained by dialysis was further fractionated by ion exchange chromatography into acidic, basic, and neutral fractions, which were analyzed for activity by in vitro agar diffusion, cell culture, and in vivo mouse assay. Neither dialysate nor fractions showed any antitumor activity when tested by agar diffusion or cell culture techniques. When tested by in vivo mouse assay, the dialyzate as well as the anionic fraction showed significant inhibitory activity. The cationic fraction showed no activity. There was no direct relationship between stage of purification and antitumor activity. Moreover, the response of the dialyzate or anionic fraction was not linear with concentration. The antitumor activity of the yogurt fraction(s) may be related to a host-mediated immunological reaction or "activation" of the "inactive" component(s).Keywords
This publication has 6 references indexed in Scilit:
- Antitumor Component(s) of Yogurt: FractionationJournal of Dairy Science, 1981
- Immunological studies on sporamycin-treated animals.The Journal of Antibiotics, 1979
- Antitumor action of glycopeptides from the cell wall of Lactobacillus bulgaricusBulletin of Experimental Biology and Medicine, 1977
- Inhibitory Effect of Yogurt on Ehrlich Ascites Tumor-Cell Proliferation2JNCI Journal of the National Cancer Institute, 1973
- Effect of streptococcal hæmolysins on Ehrlich ascites tumour cellsThe Journal of Pathology and Bacteriology, 1960